Grant Funds Will Support Proof-of-Concept Target Validation Studies for Preclinical Development of a Potential New Approach for the Prevention and...
Patent provides exclusive use of tafenoquine for prevention of malaria in malaria-naive individuals in Canada until late 2035.Tafenoquine is the...
Ms. Sullivan brings her extensive commercialization, strategy, and market access experience to the Lexicon Board of DirectorsTHE WOODLANDS, Texas, July...
VANCOUVER, BC / ACCESSWIRE / July 25, 2023 / Gemina Laboratories Ltd. (CSE:GLAB)(FRA:8I7) (the "Company" or "Gemina") is excited to...
Latest fundraising effort to strengthen Emagine’s powerful suite of maternal health toolsTUCSON, Ariz.--(BUSINESS WIRE)--Emagine Solutions Technology has been awarded $1...
Term loan facility would provide for up to $125M in non-dilutive capital; $50M immediately available to Company following close of...
Company Announcement The positive CHMP opinion is supported by results from the EPCORE™ NHL-1 phase 1/2 trial evaluating the preliminary...
Emergent has been delivering CYFENDUS™ vaccine to the U.S. Department of Health and Human Services since 2019, under pre-Emergency Use...
Results of The CAREgiver Burden in BBS (CARE-BBS) study show multifaceted burden of hyperphagiaBOSTON, July 19, 2023 (GLOBE NEWSWIRE) --...
Research shows that taking the full daily recommended amount of choline can play a crucial role in supporting maternal health...
Slynd® Slynd® is now reimbursed for 100% of Quebec women to whom it is indicated.BLAINVILLE, Quebec, July 12, 2023 (GLOBE...
SAN DIEGO, July 11, 2023 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today...
The merger will combine URA's exclusive technology and expertise with Diamond Institute's best fertility specialists to create one of the...
PRINCETON, NJ / ACCESSWIRE / July 11, 2023 / - In June, President Biden issued an Executive Order on Strengthening...
- XIPERE® is referred to as Arcatus (ARVN001) by Arctic Vision – ALPHARETTA, Ga., July 10, 2023 (GLOBE NEWSWIRE) --...
Network’s Expansion Across the U.S. and Europe Aims to Advance Translational Genomics ResearchLEXINGTON, Mass., July 06, 2023 (GLOBE NEWSWIRE) --...
YUSIMRY™ (adalimumab-aqvh) product image YUSIMRY™ (adalimumab-aqvh) - list price $995 per carton of two 40 mg/0.8 mL autoinjectorsSee https://www.yusimry.com for...
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 30, 2023 –...
Pombiliti® (cipaglucosidase alfa) + Opfolda® (miglustat) Now Approved in the European Union for Adults with Late-onset Pompe Disease (LOPD)PHILADELPHIA, June...
- Pivotal clinical trial to begin in the third quarter of 2023 - ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) --...